BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simian D, Fluxá D, Flores L, Lubascher J, Ibáñez P, Figueroa C, Kronberg U, Acuña R, Moreno M, Quera R. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients. World J Gastroenterol 2016; 22(22): 5267-5275 [PMID: 27298570 DOI: 10.3748/wjg.v22.i22.5267] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Kumar A, Harsha C, Parama D, Girisa S, Daimary UD, Mao X, Kunnumakkara AB. Current clinical developments in curcumin-based therapeutics for cancer and chronic diseases. Phytother Res 2021. [PMID: 34498308 DOI: 10.1002/ptr.7264] [Reference Citation Analysis]
2 Selvaratnam S, Gullino S, Shim L, Lee E, Lee A, Paramsothy S, Leong RW. Epidemiology of inflammatory bowel disease in South America: A systematic review. World J Gastroenterol 2019; 25(47): 6866-6875 [PMID: 31885427 DOI: 10.3748/wjg.v25.i47.6866] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
3 Ciapponi A, Virgilio SA, Berrueta M, Soto NC, Ciganda Á, Rojas Illanes MF, Rubio Martinez B, Gamba J, González Salazar CA, Rocha Rodríguez JN, Scarpellini B, Bravo Perdomo AM, Machnicki G, Aldunate L, De Paula J, Bardach A. Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study. PLoS One 2020;15:e0228256. [PMID: 31986191 DOI: 10.1371/journal.pone.0228256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Nuñez F P, Quera R, Sepúlveda E, Simian D, Pizarro G, Lubascher J, Flores L, Ibañez P, Figueroa C, Kronberg U. Pregnancy in Inflammatory Bowel Disease: Experience of a Chilean cohort. Gastroenterol Hepatol 2021;44:277-85. [PMID: 33745519 DOI: 10.1016/j.gastrohep.2020.08.005] [Reference Citation Analysis]
5 Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, Aggarwal BB. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol 2017;174:1325-48. [PMID: 27638428 DOI: 10.1111/bph.13621] [Cited by in Crossref: 352] [Cited by in F6Publishing: 326] [Article Influence: 58.7] [Reference Citation Analysis]
6 Fucilini LMP, Genaro LM, Sousa DCE, Coy CSR, Leal RF, Ayrizono MLS. EPIDEMIOLOGICAL PROFILE AND CLINICAL CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASES IN A BRAZILIAN REFERRAL CENTER. Arq Gastroenterol 2021;58:483-90. [PMID: 34909854 DOI: 10.1590/S0004-2803.202100000-87] [Reference Citation Analysis]
7 Balderramo D, Defagó MR; Grupo Córdoba de Cooperación para el Manejo y Estudio de la Enfermedad Inflamatoria Intestinal (CEMEI Group). Reply to: "Inflammatory bowel disease epidemiology data from a prospective registry in Córdoba, Argentina: Raising the bar for future studies in Latin America". Dig Liver Dis 2021;53:1214-5. [PMID: 34238667 DOI: 10.1016/j.dld.2021.06.012] [Reference Citation Analysis]
8 Sadeghian M, Rahmani S, Jamialahmadi T, Johnston TP, Sahebkar A. The effect of oral curcumin supplementation on health-related quality of life: A systematic review and meta-analysis of randomized controlled trials. J Affect Disord 2021;278:627-36. [PMID: 33038707 DOI: 10.1016/j.jad.2020.09.091] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
9 Avalos DJ, Satiya J, Contreras A, Trivedi S, Alvarado L, Dodoo C, Dwivedi AK, Zuckerman MJ. Latin Americans and US Hispanics show differences in IBD phenotype: a systematic review with meta-analysis. J Investig Med 2021:jim-2021-001846. [PMID: 34933995 DOI: 10.1136/jim-2021-001846] [Reference Citation Analysis]
10 D’Aoust J, Battat R, Bessissow T. Management of inflammatory bowel disease with Clostridium difficile infection. World J Gastroenterol 2017; 23(27): 4986-5003 [PMID: 28785153 DOI: 10.3748/wjg.v23.i27.4986] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
11 Escaffi MJ, Navia C, Quera R, Simian D. Nutrición y enfermedad inflamatoria intestinal: posibles mecanismos en la incidencia y manejo. Revista Médica Clínica Las Condes 2021;32:491-501. [DOI: 10.1016/j.rmclc.2021.01.013] [Reference Citation Analysis]
12 Simian D, Quera R. Inflammatory Bowel Disease in Latin America: A Systematic Review. Value Health Reg Issues 2019;20:19-20. [PMID: 30622033 DOI: 10.1016/j.vhri.2018.10.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
13 Juliao-Baños F, Kock J, Arrubla M, Calixto O, Camargo J, Cruz L, Hurtado J, Clavijo A, Donado J, Schwartz S, Abreu MT, Damas OM. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients. Medicine (Baltimore) 2021;100:e24729. [PMID: 33607817 DOI: 10.1097/MD.0000000000024729] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yerushalmy-Feler A, Singer D, Berkovitch G, Lubetzky R, Dotan I, Ziv-Baran T, Cohen S. Predictors for poor outcome of hospitalized children with inflammatory bowel disease. Eur J Pediatr 2020;179:157-64. [PMID: 31709474 DOI: 10.1007/s00431-019-03491-9] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Fernández A, Simian D, Quera R, Flores L, Ibáñez P, Lubascher J, Figueroa C, Kronberg U, Pizarro G, Fluxá D. Complementary and alternative medicine in patients with inflammatory bowel disease: A survey performed in a tertiary center in Chile. Complement Ther Med 2018;40:77-82. [PMID: 30219473 DOI: 10.1016/j.ctim.2018.07.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
16 Bellolio Roth F, Gómez J, Cerda J. Increase in Hospital Discharges for Inflammatory Bowel Diseases in Chile Between 2001 and 2012. Dig Dis Sci 2017;62:2311-7. [PMID: 28667431 DOI: 10.1007/s10620-017-4660-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
17 Avalos DJ, Mendoza-ladd A, Zuckerman MJ, Bashashati M, Alvarado A, Dwivedi A, Damas OM. Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis. Dig Dis Sci 2018;63:1558-71. [DOI: 10.1007/s10620-018-5022-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Dubois-Camacho K, Ottum PA, Franco-Muñoz D, De la Fuente M, Torres-Riquelme A, Díaz-Jiménez D, Olivares-Morales M, Astudillo G, Quera R, Hermoso MA. Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology. World J Gastroenterol 2017; 23(36): 6628-6638 [PMID: 29085208 DOI: 10.3748/wjg.v23.i36.6628] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 43] [Article Influence: 10.6] [Reference Citation Analysis]
19 Kotze PG, Steinwurz F, Francisconi C, Zaltman C, Pinheiro M, Salese L, Ponce de Leon D. Review of the epidemiology and burden of ulcerative colitis in Latin America. Therap Adv Gastroenterol 2020;13:1756284820931739. [PMID: 32695230 DOI: 10.1177/1756284820931739] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
20 Quaresma AB, Coy CSR, Damião AOMC, Kaplan GG, Kotze PG. BIOLOGICAL THERAPY PENETRATION FOR INFLAMMATORY BOWEL DISEASE IN LATIN AMERICA: CURRENT STATUS AND FUTURE CHALLENGES. Arq Gastroenterol 2019;56:318-22. [DOI: 10.1590/s0004-2803.201900000-59] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
21 Gutiérrez A, Zapater P, Ricart E, González-Vivó M, Gordillo J, Olivares D, Vera I, Mañosa M, Gisbert JP, Aguas M, Sánchez-Rodríguez E, Bosca-Watts M, Laredo V, Camps B, Marín-Jiménez I, Zabana Y, Martín-Arranz MD, Muñoz R, Navarro M, Sierra E, Madero L, Vela M, Pérez-Calle JL, Sainz E, Calvet X, Arias L, Morales V, Bermejo F, Fernández-Salazar L, Van Domselaar M, De Castro L, Rodríguez C, Muñoz-Villafranca C, Lorente R, Rivero M, Iglesias E, Herreros B, Busquets D, Riera J, Martínez-Montiel MP, Roldón M, Roncero O, Hinojosa E, Sierra M, Barrio J, De Francisco R, Huguet J, Merino O, Carpio D, Ginard D, Muñoz F, Piqueras M, Almela P, Argüelles-Arias F, Alcaín G, Bujanda L, Manceñido N, Lucendo AJ, Varela P, Rodríguez-Lago I, Ramos L, Sempere L, Sesé E, Barreiro-de Acosta M, Domènech E, Francés R. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients. Front Med (Lausanne) 2022;9:823900. [PMID: 35178413 DOI: 10.3389/fmed.2022.823900] [Reference Citation Analysis]
22 Chamorro N, Montero DA, Gallardo P, Farfán M, Contreras M, De la Fuente M, Dubois K, Hermoso MA, Quera R, Pizarro-Guajardo M, Paredes-Sabja D, Ginard D, Rosselló-Móra R, Vidal R. Landscapes and bacterial signatures of mucosa-associated intestinal microbiota in Chilean and Spanish patients with inflammatory bowel disease. Microb Cell 2021;8:223-38. [PMID: 34527721 DOI: 10.15698/mic2021.09.760] [Reference Citation Analysis]
23 Zobeiri M, Bashiri H, Askari L, Keshavars AA, Tavvafzadeh R, Fatahi K, Najafi F. Epidemiologic Characteristics of Patients with Inflammatory Bowel Disease in Kermanshah, Iran. Middle East J Dig Dis. 2017;9:164-169. [PMID: 28894519 DOI: 10.15171/mejdd.2017.68] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
24 Juliao-baños F, Puentes F, López R, Saffon M, Reyes G, Parra V, Galiano M, Barraza M, Molano J, Álvarez E, Corrales R, Vargas L, Gil F, Álvarez P, Limas L, Prieto R, Yance P, Díaz F, Bareño J, Juliao-baños F, Arrubla M, Camargo J, Puentes F, Arango L, López R, García R, Mendoza B, Saffon MA, Roldan LF, Zuleta J, Reyes G, Parra V, Flórez C, Nuñez E, Galiano MT, Barraza M, Sanchez IC, Molano JL, Lizarazo JI, Cuellar I, Álvarez E, Corrales R, Gil F, Vargas LE, Álvarez P, Limas LM, Prieto R, Ballén H, Delgado L, Yance P, Díaz F. Characterization of inflammatory bowel disease in Colombia: Results of a national register. Revista de Gastroenterología de México (English Edition) 2021;86:153-62. [DOI: 10.1016/j.rgmxen.2020.05.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Yamamoto-Furusho JK, Sarmiento-Aguilar A, Toledo-Mauriño JJ, Bozada-Gutiérrez KE, Bosques-Padilla FJ, Martínez-Vázquez MA, Marroquín-Jiménez V, García-Figueroa R, Jaramillo-Buendía C, Miranda-Cordero RM, Valenzuela-Pérez JA, Cortes-Aguilar Y, Jacobo-Karam JS, Bermudez-Villegas EF; EPIMEX Study Group. Incidence and prevalence of inflammatory bowel disease in Mexico from a nationwide cohort study in a period of 15 years (2000-2017). Medicine (Baltimore) 2019;98:e16291. [PMID: 31277162 DOI: 10.1097/MD.0000000000016291] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 6.7] [Reference Citation Analysis]
26 Yamamoto-Furusho JK, Parra-Holguín NN, Juliao-Baños F, Puentes F, López R, Bosques-Padilla F, Torres EA, Nieves-Jimenéz H, Veitia-Velásquez GR, Jara-Alba ML, Bautista S, Piñol-Jimenez FN, Salgado-Rosado P, Villa-Ovalles KC, Abreu-Martinez YA, Borges Z, Davila-Bedoya S, Otoya-Moreno G, Iadé-Vergara B; EPILATAM study group. Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean. Medicine (Baltimore) 2022;101:e28624. [PMID: 35060539 DOI: 10.1097/MD.0000000000028624] [Reference Citation Analysis]
27 Nóbrega VG, Silva INN, Brito BS, Silva J, Silva MCMD, Santana GO. THE ONSET OF CLINICAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS. Arq Gastroenterol 2018;55:290-5. [PMID: 30540094 DOI: 10.1590/S0004-2803.201800000-73] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
28 Acuña-Amador L, Quesada-Gómez C, Rodríguez C. Clostridioides difficile in Latin America: A comprehensive review of literature (1984-2021). Anaerobe 2022;:102547. [PMID: 35337973 DOI: 10.1016/j.anaerobe.2022.102547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Figueroa C. Epidemiología de la enfermedad inflamatoria intestinal. Revista Médica Clínica Las Condes 2019;30:257-61. [DOI: 10.1016/j.rmclc.2019.06.003] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Balderramo D, Trakal J, Herrera Najum P, Vivas M, Gonzalez R, Benavidez A, López Villa D, Daino D, Raiden K, Germán A, Corzo MA, Ponce de León J, Ferrer L, Germán C, Bálzola S, Idoeta A, Zárate F, Defagó MR. High ulcerative colitis and Crohn's disease ratio in a population-based registry from Córdoba, Argentina. Digestive and Liver Disease 2021;53:852-7. [DOI: 10.1016/j.dld.2021.01.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Juliao-Baños F, Puentes F, López R, Saffon MA, Reyes G, Parra V, Galiano MT, Barraza M, Molano J, Álvarez E, Corrales R, Vargas LE, Gil F, Álvarez P, Limas L, Prieto R, Yance P, Díaz F, Bareño J; Grupo del Registro Colombiano de Enfermedad Inflamatoria Intestinal., Grupo Registro Colombiano de Enfermedad Inflamatoria Intestinal. Characterization of inflammatory bowel disease in Colombia: Results of a national register. Rev Gastroenterol Mex (Engl Ed) 2021;86:153-62. [PMID: 32723624 DOI: 10.1016/j.rgmx.2020.05.005] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Larrosa-Haro A, Abundis-Castro L, Contreras MB, Gallo MJ, Peña-Quintana L, Targa Ferreira CH, Nacif PA, Vázquez-Frías R, Bravo S, Muñoz-Urribarri AB, Mejía-Castro M, Orsi M, Amil-Díaz J, Busoni V, Cohen-Sabban J, Martin-Capri FJ, Zablah R, Rodríguez-Guerrero MG, Sdepanian VL. Epidemiologic trend of pediatric inflammatory bowel disease in Latin America: The Latin American Society for Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN) Working Group. Rev Gastroenterol Mex (Engl Ed) 2021;86:328-34. [PMID: 34518143 DOI: 10.1016/j.rgmxen.2021.07.004] [Reference Citation Analysis]
33 Núñez F P, Quera P R, Gomollón F. Primary sclerosing cholangitis and inflammatory bowel disease: Intestine-liver interrelation. Gastroenterol Hepatol 2019;42:316-25. [PMID: 30948141 DOI: 10.1016/j.gastrohep.2019.02.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Simian D, Flores L, Quera R, Ibáñez P, Figueroa C, Lubascher J, Pizarro G, Kronberg U. The Role of an Inflammatory Bowel Disease Nurse in the Follow-Up of Patients From a Latin American Inflammatory Bowel Disease Program: . Gastroenterology Nursing 2020;43:E16-23. [DOI: 10.1097/sga.0000000000000436] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Wainstein C, Quera R, Fluxá D, Kronberg U, Conejero A, López-Köstner F, Jofre C, Zarate AJ. Stem Cell Therapy in Refractory Perineal Crohn's Disease: Long-term Follow-up. Colorectal Dis 2018. [PMID: 29316139 DOI: 10.1111/codi.14002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]